The page is the record's research on the issuer — no analyst, no rating, no view. # Herantis Pharma Oyj (First North Finland: FI4000087861) — research page As of 2026-11-06 · fi-cm-kg · record version 1 ## Identity and listing The issuer is Herantis Pharma Oyj, listed on First North Finland under ticker FI4000087861, with ISIN FI4000087861 and LEI 743700W4CQVYAT3WKK38. Its security type, segment, sector and jurisdiction are not on the record. Its listing status is listed, not halted. ## The disclosure read The record holds 31 filings on 27 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 8.5 days. The latest filing is dated 2026-11-05, one day before the record date of 2026-11-06, and is of type Investor News. The First North Finland exchange median is 7.0 days cadence, 39.5 filings and 9.0 days latency across 48 issuers. The sector median is not on the record. ## Auditor The auditor and its location are not on the record. The auditor changes are not on the record, as this register has no lifecycle type map yet. ## Events and halts Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag is listed, not halted. ## Orderability The outcome is not determinable, because the chapter's orderability section carries no client categories. The rule version is acm-68000/fi/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04. ## Coverage The issuer's investor-relations page names 2 research houses: Edison Group and Inderes. ## Open research The record holds 5 openly published research notes: Redeye, 2023-01-31; ABG Sundal Collier, 2021-02-09; Edison Investment Research, 2020-04-02; ABG Sundal Collier, 2020-02-25; and ABG Sundal Collier, 2020-02-04. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The market's vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began is not on the record. ## Sources 11 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://firds.esma.europa.eu/firds/ (identity.exchange) - https://mcp.fi-cm-kg.ai/events/FSME/FI4000087861 (the disclosure lines) - https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=exchangeNewsFilterHEX|FirstNorthInformationHEX (the halt flag) - https://fi.eu-cm-kg.ai/book/aio.json (the orderability chapter) - https://herantis.com/investors/analyst-coverage/ (coverage) - https://herantis.com/wp-content/uploads/2023/02/Redeye-equity-research-update-January-of-Herantis-2023-English.pdf (open research) - https://herantis.com/wp-content/uploads/2021/02/ABG-in-depth-research-February-9.pdf (open research) - https://herantis.com/wp-content/uploads/2020/04/Herantis-Pharma-Funded-to-key-data-inflection-points.pdf (open research) - https://herantis.com/wp-content/uploads/2020/04/ABG_Impressions_from_capital_markets_day_2020-03-25.pdf (open research) - https://herantis.com/wp-content/uploads/2020/02/ABG_Herantis_Initiation_2020-02-04.pdf (open research) - https://mcp.fi-cm-kg.ai/record/FSME/FI4000087861 (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/fi/FSME/FI4000087861 · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp